FDA Approves Lembaz (adrabetadex) to Improve Survival in Infantile-Onset Niemann-Pick Disease, Type C

Nov 18, 2026 - 03:00
 0  0
THOUSAND OAKS, Calif., November 17, 2026 – Beren Therapeutics P.B.C., a leader in cholesterol-trafficking biology and novel cyclodextrin-based therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has approved Lembaz...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0